NKGen Biotech (NKGNW) Competitors $0.09 0.00 (0.00%) (As of 11/14/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends NKGNW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying NKGen Biotech stock or one of its competitors? The main competitors of NKGen Biotech include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. NKGen Biotech vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and NKGen Biotech (NASDAQ:NKGNW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations. Does the media favor ATNFW or NKGNW? In the previous week, NKGen Biotech had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for NKGen Biotech and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat NKGen Biotech's score of 0.43 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive NKGen Biotech Neutral Does the MarketBeat Community favor ATNFW or NKGNW? 180 Life Sciences and NKGen Biotech both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ANKGen BiotechN/AN/A Is ATNFW or NKGNW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A NKGen Biotech N/A N/A N/A Which has higher valuation & earnings, ATNFW or NKGNW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ANKGen Biotech$77KN/AN/AN/AN/A SummaryNKGen Biotech beats 180 Life Sciences on 2 of the 3 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get NKGen Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NKGNW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NKGNW vs. The Competition Export to ExcelMetricNKGen BiotechBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$120.78M$5.37B$8.88BDividend YieldN/A3.71%5.06%4.03%P/E RatioN/A310.30126.8117.46Price / SalesN/A15,578.121,259.1792.80Price / CashN/A11.2439.3636.42Price / BookN/A7.616.285.86Net IncomeN/A-$12.95M$119.59M$225.15M7 Day PerformanceN/A10.04%-1.08%-0.90%1 Month PerformanceN/A14.36%3.63%3.70%1 Year PerformanceN/A31.27%36.58%26.40% NKGen Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NKGNWNKGen BiotechN/A$0.09flatN/A-20.9%$0.00$77,000.000.0063Short Interest ↑ATNFW180 Life SciencesN/A$0.01+2.2%N/A-19.1%$0.00N/A0.007Gap DownSXTPW60 Degrees PharmaceuticalsN/A$0.01+2.4%N/A-78.3%$0.00$418,304.000.002Positive NewsGap UpDRTSWAlpha Tau MedicalN/A$0.20+5.2%N/AN/A$0.00N/A0.0080News CoverageGap DownHigh Trading VolumeWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01-2.6%N/A-71.0%$0.00N/A0.0059Short Interest ↓Positive NewsHigh Trading VolumeBCTXWBriaCell TherapeuticsN/A$0.30+1.7%N/A-79.8%$0.00N/A0.008Short Interest ↓Gap DownCDIOWCardio DiagnosticsN/A$0.04+5.1%N/A-43.5%$0.00$39,138.000.007Positive NewsGap DownCTCXWCarmellN/A$0.11+29.4%N/AN/A$0.00$12,320.000.009Positive NewsCELUWCelularityN/A$0.03+38.9%N/A-10.0%$0.00$33.52M0.00220Gap UpHigh Trading VolumeCEROWCERo TherapeuticsN/A$0.01+51.5%N/AN/A$0.00N/A0.008Short Interest ↓Positive NewsGap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 60 Degrees Pharmaceuticals Competitors Alpha Tau Medical Competitors Anew Medical Competitors Apollomics Competitors BriaCell Therapeutics Competitors Cardio Diagnostics Competitors Carmell Competitors Celularity Competitors CERo Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NKGNW) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NKGNW Stock Alerts